Forskolin is renowned for its ability to stimulate adenylyl cyclase, thereby amplifying cAMP levels within the cell. This surge in cAMP activates protein kinase A, which targets numerous proteins for phosphorylation, potentially altering their activity states. Ionomycin exerts its effects by increasing intracellular calcium concentrations, a critical factor for proteins that are regulated by calcium ions. This increase can activate a suite of calcium-dependent protein kinases, which in turn may phosphorylate and thereby regulate proteins akin to WDR69. Phorbol esters, exemplified by PMA, are known to directly bind to and activate protein kinase C. This activation results in the phosphorylation of serine and threonine residues on a multitude of proteins, which may include those that are part of or regulated by the PKC signaling pathways. Similarly, analogs of cAMP, such as 8-Bromo-cAMP, bypass cellular receptors and directly activate PKA, leading to targeted phosphorylation events.
Epigenetic modulators like 5-Azacytidine and Trichostatin A alter the transcriptional landscape within cells. By inhibiting DNA methyltransferases and histone deacetylases, respectively, these compounds can result in the upregulation of genes and the consequent increase in protein expression, which could affect the levels and function of numerous proteins. Within the realm of kinase signaling, LY294002, U0126, SB203580, and PD98059 are notable for their roles in modulating the activity of key signaling pathways. By targeting PI3K, MEK, and p38 MAPK respectively, these inhibitors can lead to compensatory responses within the cell that might activate or enhance the expression of proteins involved in those pathways. Thapsigargin, by disrupting calcium homeostasis through inhibition of the SERCA pump, can provoke a rise in cytosolic calcium levels, similarly leading to the activation of calcium-dependent signaling processes. Okadaic Acid, a potent inhibitor of protein phosphatases, sustains proteins in their phosphorylated state, prolonging their activated condition.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Elevates intracellular Ca2+ levels, which may activate calcium-dependent protein kinases that phosphorylate target proteins, including WDR69 if it is Ca2+-sensitive. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which phosphorylates serine and threonine residues on target proteins that are part of or regulated by PKC signaling. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates PKA, leading to the phosphorylation of target proteins involved in cAMP-dependent pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can lead to the demethylation and activation of gene expression, possibly upregulating proteins involved in specific pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylases, which can result in altered gene expression and upregulation of proteins including those in signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can lead to altered phosphorylation patterns and activation of downstream proteins involved in the PI3K/Akt pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK, which may lead to compensatory activation of parallel signaling pathways, potentially upregulating proteins like WDR69. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can alter signaling dynamics and lead to the activation of compensatory pathways, potentially affecting proteins in those pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor that leads to increased cytosolic calcium levels and could activate calcium-dependent proteins. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins within affected signaling pathways. | ||||||